Induced pluripotent stem cells (iPSCs)

CELL AND GENE THERAPY INSIGHTS

Induced pluripotent stem cells (iPSCs)

February 2024
Induced pluripotent stem cells (iPSCs)
Download PDF

Review

AI and iPSCs: current applications for characterization and quality control

AI and iPSCs: current applications for characterization and quality control

Jonathan Dack
26 March
Read

Commentary

Unlocking the full potential of human induced pluripotent stem cells from haplo-selected cord blood samples—the how and the why

Unlocking the full potential of human induced pluripotent stem cells from haplo-selected cord blood samples—the how and the why

B Aran, D Morrow, E Rodriguez et al.
14 February
Read

Viewpoint

Autologous induced pluripotent stem cell (iPSC)-derived therapies: a realistic solution for advancing regenerative medicine

Autologous induced pluripotent stem cell (iPSC)-derived therapies: a realistic solution for advancing regenerative medicine

Jarett Anderson, Timothy Nelson
17 January
Read
Following the (mAb) leader: leveraging monoclonal antibody cell line development & banking CMC strategies for iPSC-derived cell therapies

Following the (mAb) leader: leveraging monoclonal antibody cell line development & banking CMC strategies for iPSC-derived cell therapies

Damien Fink
17 January
Read

Interview

Exploring the frontiers of iPSC research, clinical application, and standardization

Exploring the frontiers of iPSC research, clinical application, and standardization

Julie Allickson
28 February
Read
Blazing a trail for iPSC-derived cell therapy in the hair loss space

Blazing a trail for iPSC-derived cell therapy in the hair loss space

Kevin D’Amour
15 February
Read

Webinars

iPSC-based therapy dilemmas explored: overcoming hurdles for future success

iPSC-based therapy dilemmas explored: overcoming hurdles for future success

L Munsie, K Raineri, M Carpenter et al.
5 March
Watch
iPSC cell line development and manufacture for cell therapies

iPSC cell line development and manufacture for cell therapies

R Flynn, B Ressler, D Hei et al.
14 March
Watch